GTCM
Gyon Technologies Capital Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-16,834
| Closed | -$750K | – | 96 |
|
|
2022
Q4 | $750K | Buy |
16,834
+5,881
| +54% | +$262K | 0.28% | 115 |
|
|
2022
Q3 | $308K | Sell |
10,953
-2,965
| -21% | -$83.4K | 0.1% | 272 |
|
|
2022
Q2 | $375K | Buy |
13,918
+3,366
| +32% | +$90.7K | 0.11% | 217 |
|
|
2022
Q1 | $359K | Sell |
10,552
-7,836
| -43% | -$267K | 0.25% | 139 |
|
|
2021
Q4 | $711K | Sell |
18,388
-17,376
| -49% | -$672K | 0.13% | 213 |
|
|
2021
Q3 | $1.93M | Buy |
+35,764
| New | +$1.93M | 0.52% | 63 |
|